Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Serimmune is a company that studies immunity to find out how environmental factors affect health and disease.
Desktop Genetics is a biotechnology company to helps researchers discover and treat the root genetic causes of human disease.
Biota is pioneering biosurveillance across industrial sectors
Illumina Ventures has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Illumina Ventures's top investment sectors include Biotechnology, Genetics, Health Care, Therapeutics, Information Technology. The firm invests across 11 different industry categories.
Among tracked funding rounds, SerImmune received $12.0M in a Series Unknown round. Illumina Ventures's total known invested capital is $1.4B.
Illumina Ventures's average investment size is $27.8M across its portfolio of 52 companies.
Recent Illumina Ventures portfolio additions include Encoded Therapeutics, SerImmune. These companies were founded in 2020 or later.